Related references
Note: Only part of the references are listed.Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS Management
Shiqi Li et al.
CLINICAL CANCER RESEARCH (2021)
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial
Jing Pan et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Base-edited CAR T cells for combinational therapy against T cell malignancies
Christos Georgiadis et al.
LEUKEMIA (2021)
An off-the-shelf fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
Matthew L. Cooper et al.
LEUKEMIA (2018)
Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies
Yi Tian Png et al.
BLOOD ADVANCES (2017)
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
Diogo Gomes-Silva et al.
BLOOD (2017)
The immunophenotype of pre-TALL/LBL revisited
Robert E. Lewis et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)